PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/11/01	06:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/11/01	05:16	Business Wire	Personalis Grows Leadership Team with Appointment of Christopher Hall as Senior Vice President and Head, Diagnostics Business	NASDAQ:PSNL	Personalis Inc
2022/10/20	05:01	Business Wire	Personalis to Announce Third Quarter 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2022/10/04	22:00	Business Wire	Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer	NASDAQ:PSNL	Personalis Inc
2022/10/03	23:25	TipRanks	Needham Sticks to Its Hold Rating for Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/10/03	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/09/23	05:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/09/23	05:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/09/09	05:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/08/31	05:01	Business Wire	Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference	NASDAQ:PSNL	Personalis Inc
2022/08/18	06:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/08/18	06:01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/08/18	05:15	Business Wire	Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics	NASDAQ:PSNL	Personalis Inc
2022/08/17	05:05	Business Wire	Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PSNL	Personalis Inc
2022/08/15	21:55	Business Wire	Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers	NASDAQ:PSNL	Personalis Inc
2022/08/05	06:48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/08/05	06:40	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PSNL	Personalis Inc
2022/08/05	05:01	Business Wire	Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference	NASDAQ:PSNL	Personalis Inc
2022/08/04	19:48	TipRanks	Personalis (PSNL) Receives a Hold from Needham	NASDAQ:PSNL	Personalis Inc
2022/08/04	05:21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PSNL	Personalis Inc
2022/08/04	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/08/04	05:01	Business Wire	Personalis Reports Second Quarter 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2022/08/03	05:10	Business Wire	Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics	NASDAQ:PSNL	Personalis Inc
2022/08/02	07:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/07/21	05:01	Business Wire	Personalis to Announce Second Quarter 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2022/07/13	05:05	Business Wire	Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease	NASDAQ:PSNL	Personalis Inc
2022/06/22	05:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/06/22	05:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/06/18	06:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/06/07	06:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc